Consume Responsibly: Not recommended for children, people sensitive to caffeine, pregnant women, or women who are nursing
The OASIS 4 trial, which investigated the effectiveness of oral semaglutide, found that the average weight loss after 64 weeks at the maximum maintenance dose was 16.6%
What clinical trials show Large-scale clinical trials have measured average weight loss across thousands of participants: Wegovy (semaglutide 2.4 mg) : Participants in the STEP 1 trial lost an average of 14.9% of their body weight over 68 weeks
Third-party testing certificates, proper lyophilization, and sealed vials under vacuum are all quality indicators worth verifying before you ever begin reconstitution
They aid regeneration of compromised or miniaturized follicles
Some experience less food noise, which means fewer nighttime cravings that can disrupt sleep